Affiliations 

  • 1 Department of Biochemistry, Indian Institute of Science, Bengaluru, Karnataka, India
  • 2 Department of Maxillofacial Surgery and Diagnostic Science, King Saud Bin Abdulaziz University of Health Sciences, Riyadh, Saudi Arabia
  • 3 Department of Chemistry, University of Malaya, Kuala Lumpur, Malaysia
Int J Clin Pract, 2021 Jun;75(6):e14141.
PMID: 33715304 DOI: 10.1111/ijcp.14141

Abstract

The current global pandemic COVID-19 challenges oncologists to reorganise cancer care in order to strikingly reduce hospital visits and admissions. Cancer patients are more susceptible to infections and likely to get severe consequences compared with other patients. Health-care facility services are quickly changing their systems and workflow in response to the global pandemic COVID-19 crisis. These alterations mitigate infection risks and give profound effects on crucial aspects of care, including patients with cancer. Here, we discuss the current situations and a roadmap for cancer care during the COVID-19 crisis. In the prevalence of global cancer and higher transmission of pandemic COVID-19, there is an urgent need to realise the effect of SARS-CoV-2 infection and their related life-threatening outcomes specifically for cancer patients.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.